US Patent Issued to Carbon Biosciences on Aug. 12 for "Protoparvovirus compositions comprising a protoparvovirus variant VP1 capsid polypeptide and related methods" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,615, issued on Aug. 12, was assigned to Carbon Biosciences Inc. (Waltham, Mass.).

"Protoparvovirus compositions comprising a protoparvovirus variant VP1 capsid polypeptide and related methods" was invented by Robert Kotin (Cambridge, Mass.), Sebastian Aguirre Kozlouski (Cambridge, Mass.) and Carolyn Pelletier (Salem, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides technologies comprising compositions, preparations, constructs, and methods comprising a protoparvovirus variant VP1 capsid polypeptide."

The patent was filed on March 22, 2024, under Application No. 18/614,158.

*For further information, including ima...